Xilio Therapeutics (XLO) Q4 2025 Earnings

13NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.54
-1.05
-0.57
-0.08

Details

Expected EPS
-0.4466
Actual EPS
-1.54
Surprise EPS
-1.09
Surprise Percent
+244.83%

Description

Xilio Therapeutics (XLO) has reported earnings of -1.54 per share for Q4 2025.

0 Comments

Share your thoughts